Advertisement

Topics

Green light for Celltrion’s Herceptin biosimilar

02:51 EST 15 Feb 2018 | PharmaTimes

The European Commission has approved Celltrion Healthcare’s Herzuma, a biosimilar of Roche/Genentech’s blockbuster Herceptin.

Original Article: Green light for Celltrion’s Herceptin biosimilar

NEXT ARTICLE

More From BioPortfolio on "Green light for Celltrion’s Herceptin biosimilar"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...